AngioLab, Inc. engages in the development, manufacture, and distribution of pharmaceutical products. Its products include medicines for ophthalmic disorders, periodontal diseases, anti-obesity drugs, anti-inflammation treatments, and psoriasis cares, health functional foods for internal organ fat controls, and cosmetics for anti-wrinkle. The company was founded by Kim Min-Yeong on June 3, 1999 and is headquartered in Daejeon, South Korea.
Headquarters
65 Techno 3Ro, Yuseong-Gu
Daejeon; Daejeon;
Contact Details: Purchase the Angiolab Inc. report to view the information.
Website: http://www.angiolab.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service